James W Hodge Selected Research

James W Hodge Research Topics

Disease

113	Neoplasms (Cancer) 12/2021 - 01/2002
23	Carcinoma (Carcinomatosis) 02/2021 - 06/2004
17	Prostatic Neoplasms (Prostate Cancer) 11/2018 - 05/2005
16	Vaccinia 09/2015 - 01/2002
11	Fowlpox 05/2014 - 10/2002
10	Neoplasm Metastasis (Metastasis) 10/2017 - 03/2007
7	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2014
5	Chordoma 12/2021 - 05/2016
4	Mouth Neoplasms (Oral Cancer) 01/2020 - 01/2016
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 04/2017
4	Squamous Cell Carcinoma of Head and Neck 01/2020 - 03/2006
3	Disease Progression 01/2020 - 01/2007
3	Colorectal Neoplasms (Colorectal Cancer) 10/2015 - 09/2002
2	Triple Negative Breast Neoplasms 01/2021 - 04/2016
2	Hematologic Neoplasms (Hematological Malignancy) 07/2020 - 08/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2003
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2018 - 02/2012
2	Lung Neoplasms (Lung Cancer) 08/2014 - 06/2008

Drug/Important Bio-Agent (IBA)

54	VaccinesIBA 02/2021 - 01/2002
49	AntigensIBA 12/2021 - 01/2002
23	Cancer VaccinesIBA 05/2021 - 09/2002
15	Neoplasm Antigens (Tumor Antigens)IBA 01/2021 - 10/2004
15	Carcinoembryonic AntigenIBA 05/2016 - 09/2002
10	Monoclonal AntibodiesIBA 01/2020 - 06/2005
9	Interleukin-15 (Interleukin 15)IBA 12/2021 - 03/2007
8	Immune Checkpoint InhibitorsIBA 05/2021 - 06/2013
8	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2016 - 10/2002
7	avelumabIBA 01/2020 - 06/2016
7	Proteins (Proteins, Gene)FDA Link 10/2017 - 01/2006
6	Immunoglobulin G (IgG)IBA 11/2018 - 06/2016
6	Biological ProductsIBA 01/2014 - 06/2003
6	AutoantigensIBA 01/2006 - 01/2002
5	LigandsIBA 12/2021 - 06/2013
5	Cetuximab (Erbitux)FDA Link 12/2021 - 12/2016
5	Granzymes (Granzyme)IBA 01/2020 - 02/2012
5	PerforinIBA 01/2017 - 09/2002
5	Brachyury protein (Brachyury)IBA 12/2016 - 10/2013
4	Chimeric Antigen ReceptorsIBA 12/2021 - 01/2020
4	ALT-803IBA 01/2021 - 01/2020
4	PlatinumIBA 01/2020 - 09/2011
4	CytokinesIBA 01/2020 - 07/2009
4	Death Domain ReceptorsIBA 01/2020 - 06/2004
4	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 03/2006
4	Interleukin-2 (IL2)IBA 12/2016 - 05/2003
4	CalreticulinIBA 12/2016 - 01/2014
4	enzalutamideIBA 04/2016 - 11/2013
4	PROSTVACIBA 10/2015 - 07/2009
4	B7 AntigensIBA 09/2015 - 10/2002
4	Prostate-Specific Antigen (Semenogelase)IBA 02/2014 - 05/2005
4	CD58 Antigens (LFA-3)IBA 05/2008 - 10/2002
3	AntibodiesIBA 12/2021 - 12/2016
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2021 - 03/2010
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2021
3	Docetaxel (Taxotere)FDA Link 01/2021 - 06/2008
3	Histone Deacetylase InhibitorsIBA 01/2020 - 02/2016
3	entinostat (MS 275)IBA 01/2020 - 02/2016
3	Pharmaceutical PreparationsIBA 01/2019 - 06/2008
3	InterleukinsIBA 04/2018 - 03/2007
3	EpitopesIBA 01/2017 - 09/2002
3	Transcription Factors (Transcription Factor)IBA 06/2016 - 10/2013
3	AndrogensIBA 04/2016 - 10/2014
3	Sunitinib (Sutent)FDA Link 01/2015 - 04/2012
3	Synthetic Vaccines (Recombinant Vaccines)IBA 11/2014 - 12/2007
3	Hormones (Hormone)IBA 10/2014 - 01/2007
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 03/2007 - 05/2003
2	B7-H1 AntigenIBA 12/2021 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2018
2	Estrogen ReceptorsIBA 01/2021 - 04/2016
2	EnzymesIBA 01/2021 - 05/2014
2	olaparibIBA 01/2020 - 11/2018
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 02/2016
2	Vorinostat FDA Link 01/2018 - 02/2016
2	Twist-Related Protein 1IBA 10/2017 - 09/2015
2	Protons (Proton)IBA 12/2016 - 05/2016
2	RadiopharmaceuticalsIBA 12/2016 - 07/2008
2	Mucin-1 (CA 15-3 Antigen)IBA 05/2016 - 07/2008
2	abirateroneIBA 04/2016 - 10/2014
2	Androgen Receptors (Androgen Receptor)IBA 04/2016 - 10/2014
2	Androgen Receptor AntagonistsIBA 09/2015 - 11/2013
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 11/2014
2	Sorafenib (BAY 43-9006)FDA Link 01/2015 - 11/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 11/2014
2	cabozantinibIBA 01/2015 - 11/2014
2	Interferon-gamma (Interferon, gamma)IBA 05/2014 - 09/2002
2	Adenosine Triphosphate (ATP)IBA 01/2014 - 08/2013
2	HMGB1 Protein (HMG1)IBA 01/2014 - 08/2013
2	Vinorelbine (Navelbine)FDA LinkGeneric 02/2012 - 09/2011
2	Fas Ligand Protein (Fas Ligand)IBA 08/2008 - 06/2004
2	Therapeutic UsesIBA 06/2006 - 03/2005
2	Peptides (Polypeptides)IBA 01/2006 - 09/2002
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021
1	afimoxifene (hydroxytamoxifen)IBA 01/2021

Therapy/Procedure

52	Therapeutics 12/2021 - 01/2003
51	Immunotherapy 12/2021 - 06/2003
16	Radiotherapy 01/2018 - 06/2003
15	Drug Therapy (Chemotherapy) 01/2021 - 01/2006
5	Castration 12/2016 - 07/2009
3	Aftercare (After-Treatment) 01/2016 - 01/2012
2	Immunomodulation 08/2014 - 08/2014
1	Combined Modality Therapy 12/2021